Benchmark analyst Robert Wasserman lowered the price target on Anebulo Pharmaceuticals (NASDAQ: ANEB) to $10.00 (from $15.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE